The TB Alliance is a prominent member of the Stop TB Partnership Working Group on New Drugs (WGND, www.newtbdrugs.org), providing funding for WGND activities and hosting the WGND Secretariat. The Fellow will assist the WGND Secretariat by coordinating activities to help the working group achieve its annual objectives as mandated by its membership. The Fellow/Intern will work with a broad range of stakeholders from the drug R & D field as well as the global health and advocacy communities.
The fellowship is designed to be a short term (up to six months) work experience of 10-15 hours per week, with the potential for an extension for an additional six months.
- Develop knowledge on:
- advances in basic research on M. tuberculosis biology,
- tools developed to aid new TB drug R & D,
- lead compounds identified,
- clinical trials and regulatory processes that will impact new TB drug R & D,
- developments in global health advocacy and
- the networks of centers of excellence around the world that are necessary to the development of new drugs for infectious diseases.
- Assist WGND subgroups with planning and completing specific projects and initiatives.
- Maintain and routinely update the online global drug pipeline (s), discovery portfolio, and biologics pipeline.
- Coordinate the development and maintenance of online resource tools including content on the WGND website including but not limited to the Clinical Trials Database, Grants Finder, Meetings, Targets Database, InnovateTB, and Blog.
- Track, synthesize and disseminate information through social media channels and WGND blog.
- Assist with synthesizing information about WGND activities for various documents, reports, and presentations.
- Assist with the planning and coordination of symposia, conferences, and the annual meeting.
- Manage and administer WGND membership including keeping membership aware of WGND activities, events and news.
- Assist with the implementation of strategies to engage the TB research and advocacy community to further the mission of the WGND
Schedule and document quarterly meetings with the WGND Core Group and membership
Ideal candidates will have
1) This fellowship/internship is designed for an individual who is a candidate for a Ph.D. in biomedical science, or a recent graduate. Prefereably, in the individual is focused in infectious disease research and has a demonstrated interest in a career in global health and /or drug development. Exceptional individuals who are candidates for a Masters degree in Biology/Public Health and a minimum of 1-2 years of experience with a strong grounding in biomedical science will also be considered.
2) Excellent writing with clear and concise style; superior grammar, editorial and proofreading abilities.
3) Good computer skills; database or other information management experience desired.
4) Experience and aptitude in conducting research, especially via the internet.
5) Experience and aptitude with updating web portals using content management software desired.
6) Ability to adapt quickly to changing needs and priorities; proven ability to prioritize and manage multiple tasks simultaneously with little direction.
7) Organized, detail oriented, and flexible. Resourcefulness is critical.
8) Excellent interpersonal skills; ability to communicate and work with people from different cultures and different levels of authority.
Ability to work in a team and individually; quick learner with ability to work under pressure.
Commensurable with experience
New York, NY
The TB Alliance is an international product development partnership (PDP) created to accelerate the development and adoption of urgently needed new anti-tuberculosis (TB) drugs. The TB Alliance is preeminent in the TB drug development field and is pursuing faster, simpler treatments for all forms of TB through an innovative business model that bridges the expertise and functionality of industry with academic and public sector interests to meet a major unmet global health need.
Tuberculosis kills nearly 1.5 million each year. Yet, current treatments are antiquated, inadequate, and excessively burdensome. Long, demanding treatment schedules prove too much for many patients, leading to the emergence of multi- and extensively- drug-resistant TB (MDR-TB and XDR-TB), which are exponentially more expensive and difficult to treat.
Based in New York City, with an office in Pretoria, South Africa, the TB Alliance, a not-for profit, functions through strategic relationships with pharmaceutical companies, academic institutions, research labs, and governmental agencies, and deploys preferred service providers for contract research. With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Currently, a portfolio of more than 20 projects spans from target validation to Phase III clinical development. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website: www.tballiance.org.
Please send your resume to email@example.com with 'fellowship/internship' as the subject matter.
How to Apply
se send your resume to firstname.lastname@example.org with 'fellowship/internship' as the subject matter.
The TB Alliance prohibits discrimination against any employee or applicant for employment because of the individual's race, color, sex, religion, national origin, age, sexual orientation, disability, gender identity or expression, marital status, genetic predisposition or carrier status, military status or any other characteristic protected by law. This policy applies to all of the TB Alliance's activities, including but not limited to, recruitment, hiring, compensation, assignment, training, promotion, discipline and discharge.